Attorneys have filed a class action suit against a successful Florida-based supplement manufacturer, claiming their bodybuilding supplements “contain a dangerous amphetamine-like ingredient that poses a serious health risk and has potentially life-threatening side effects.”
BPI Sports manufactures and sells multiple dietary supplements, including 1.M.R powder and tablets, RoxyLean ECA and Rx6. Marketed as bodybuilding and weight loss supplements, the products contain DMAA, a known stimulant that has been banned by multiple organizations and several countries. Both the World Anti-Doping Agency and Major League Baseball prohibit the use of DMAA, and Canada and New Zealand have prohibited the sale of the substance.
According to the class action lawsuit, BPI failed to inform customers that its products contain a dangerous stimulant. Don Caitlin, an anti-doping scientist, told the Washington Post that DMAA is chemically similar to amphetamine and ephedrine, and can raise one’s heart rate and blood pressure to fatal levels.
The plaintiffs in the class action are seeking restitution and class damages for consumer law violations, unfair competition, false and misleading advertising, breach of express warranty and breach of implied warranty.
Have you used a dietary supplement that contains DMAA and are considering legal action? If you have questions about your legal options, please contact our Miami class action attorneys for a free consultation.
Sarelson Law Firm – Miami class action attorneys